Table 2. Comparison between recurrent and non-recurrent furunculosis regarding different predictors studied

 

 

Predictors

Furunculosis

 

 

OR (95% CI)

Recurrent

N(%)

Non-recurrent

N(%)

Residence:

 

Rural

Urban

51(68.9)

23(31.1)

47(63.5)

27(36.5)

1(r)

0.8(0.4-1.6)

Sex:

 

Male

Female

41(55.4)

33(44.6)

46(62.2)

28(37.8)

1(r)

1.3(0.7-2.7)

Age:

 

<10 years

10-

20+

28(37.8)

19(25.7)

27(36.5)

27(36.5)

17(23.0)

30(40.5)

1(r)

1.1(0.4-2.7)

0.9(0.4-2.0)

Crowding index at sleep#:

One or less

More than one

11(14.9)

63(85.1)

28(37.8)

46(62.2)

1(r)

3.5(1.5-8.4)**

Social class:

 

High

Middle

Low/Very low

11(14.9)

31(41.9)

32(43.2)

14(18.9)

35(47.3)

25(33.8)

1(r)

1.1(0.4-3.2)

1.6(0.6-4.7)

Current smoking:

 

No

Yes

58(78.4)

16(21.6)

66(89.2)

8(10.8)

1(r)

2.3(0.8-6.3)

Personal hygiene:

 

Good

Poor

32(43.2)

42(56.8)

55(74.3)

19(25.7)

1(r)

3.8(1.8-8.1)***

Obesity:

No

Yes

63(85.1)

11(14.9)

72(97.3)

2(2.7)

1(r)

6.3(1.2-42.8)**

Family history:

 

No

Yes

26(35.1)

48(64.9)

58(78.4)

16(21.6)

1(r)

6.7(3.0-14.9)***

Immunosuppressive therapy:

No

Yes

56(75.7)

18(24.3)

68(91.9)

6(8.1)

1(r)

3.6(1.3-11.1)**

Previous hospitalization:

No

Yes

44(59.5)

30(40.5)

59(79.7)

15(20.3)

1(r)

2.7(1.2-6.0)**

Previous antibiotics therapy:

No

Yes

15(20.3)

59(79.7)

48(64.9)

26(35.1)

1(r)

7.3(3.3-16.4)***

Anemia:

 

No

Yes

26(35.1)

48(64.9)

47(63.5)

27(36.5)

1(r)

3.1(1.6-6.7)***

Diabetes mellitus:

 

No

Yes

15(20.3)

59(79.7)

31(41.9)

43(58.1)

1(r)

2.8(1.3-6.3)**

Multiplicity of lesion:

Single

Multiple

33(44.6)

41(55.4)

50(67.6)

24(32.4)

1(r)

2.6(1.3-5.4)**

Associated skin diseases ##:

No

Yes##

20(27.0)

54(73.0)

57(77.0)

17(23.0)

1(r)

9.1(4.0-20.6)***

S. aureus nasal culture:

Negative

Positive

43(58.1)

31(41.9)

50(67.6)

24(32.4)

1(r)

1.5(0.7-3.1)

OR= Odds ratio, CI= Confidence Interval, r= reference group.

# crowding index at sleep = family size/number of bed rooms

## e.g., Acne, fungal infections, psoriasis, etc.

**,*** Significant difference in comparison to the reference group at P=0.01 and 0.001, respectively.